be_ixf;ym_202602 d_21; ct_50
NYSE:KMX charts & data provided by TradingView

Latest Insights on KMX

Drama builds in the electric-vehicle market as Tesla and Nikola go head to head, while Ford jaunts off to Germany with Volkswagen. Nikola Vs. Tesla; Uber Out; GameStopped June 10, 2020 by Joseph Hargett Great Stuff The EV Soap Opera Drama Like sands through the hourglass, so are the days of electric-vehicle (EV) lives! In yesterday’s episode of EV Days, upstart Nikola Corp. (Nasdaq: NKLA) tried to take advantage of a weakened Tesla Inc. (Nasdaq: TSLA). While Tesla still recuperated in a hospital bed from a nasty virus, Nikola announced that […]
Apple and Tesla: Is Either Worth Buying? January 13, 2020 by Ted Bauman Big Picture. Big Profits., Stocks, Technology [11-min. video]. Is the market irrationally valued? Is Apple? Is Tesla?
Great Stuff 9-24-2019 Google Won’t Forget You … Ever; Snap Hands Over Project Voldemort September 24, 2019 by Joseph Hargett Great Stuff Gone, but Never Forgotten Today, we’re going to talk about digital privacy. It’s not a sexy topic by any means. But it’s a vitally important one. Earlier today, Europe’s highest court ruled in favor of Alphabet Inc.’s (Nasdaq: GOOG) Google. The case centered on Google users’ “right to be forgotten.” At its core, “right to […]
Great Stuff 7-1-2019 The Trade War Truce Rally: AMD, Apple, Nvidia and Oil? July 1, 2019 by Joseph Hargett Great Stuff Today’s G-20 rally is no surprise. There was no way President Donald Trump was coming out of the G-20 meeting without a win — one way or another. And he certainly got a win. I’m not talking about the pause in the trade war — that was a given. It fits Trump’s M.O. to a […]
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

Share This